MEDITE CANCER DIAGNOSTICS INC COM NEW shareholder history

Current and past MEDITE CANCER DIAGNOSTICS INC COM NEW shareholders
Period Weighting Quarter
CompanyLongestShortestMin.Avg.Max.FirstLatest↓ Count
CAPTRUST FINANCIAL ADVISORS 110.00%0.00%0.00%Q2 2020Q2 20201
External links

This page lists all the filers that currently own MEDITE CANCER DIAGNOSTICS INC COM NEW or have owned MEDITE CANCER DIAGNOSTICS INC COM NEW in the past.